Greco R, Piastra M, Iacovacci V, Belcastro F, Forastiere E M, Proietti S, Piastra L
Servizio di Anestesia e Rianimazione, Ospedale Cristo Re, Roma.
Minerva Anestesiol. 1994 Oct;60(10 Suppl 2):1-8.
We herein evaluated the analgesic effectiveness of low doses of buprenorphine with or without a primer and the practicality and usefulness of a constant flow disposable infusion set (Infusor Baxter 2 ml/h). Our series consists of 300 patients, seen between January 1992 and December 1993, randomly distributed in three groups of 100 patients each. All patients were informed before operation about the use of pain Visual Analogical Scale (VAS) and how the infusor works. At the end of the operation all patients had an infusor positioned with a 0.01 mg/kg supplied of buprenorphine diluted to 60 ml with Ringer's Lactate solution. In addition to this, group B patients received an i.v. primer of 0.003 mg/kg of buprenorphine diluted to 10 ml with saline solution and group C patients received an i.v. primer of 0.5 mg/kg of ketorolac diluted to 10 ml with saline solution. VAS, systolic arterial pressure, diastolic arterial pressure, heart rate, respiratory rate, request of analgesics and side effects were evaluated at one hour (T0), six hours (T1), 12 hours (T2), 24 hours (T3) and 36 hours (T4) after operation. Group B and C patients showed significant reduction in VAS compared to group A patients at T0 and T1 but the difference disappeared starting from T2. Group B and C patients showed blood pressure, heart rate and respiratory rate values significantly reduced compared to group A patients at T0 and T1. Such values however then stabilized. Side effects encountered were nausea and vomiting in different percentages in the three groups.(ABSTRACT TRUNCATED AT 250 WORDS)
我们在此评估了低剂量丁丙诺啡(无论有无初始剂量)的镇痛效果以及恒流一次性输液装置(百特输液器,2毫升/小时)的实用性和有效性。我们的研究系列包括300例患者,于1992年1月至1993年12月期间就诊,随机分为三组,每组100例。所有患者在手术前均被告知疼痛视觉模拟评分法(VAS)的使用方法以及输液器的工作原理。手术结束时,所有患者均放置了输液器,其中含有以乳酸林格氏液稀释至60毫升的0.01毫克/千克丁丙诺啡。除此之外,B组患者接受了静脉注射初始剂量,即0.003毫克/千克丁丙诺啡用生理盐水稀释至10毫升,C组患者接受了静脉注射初始剂量,即0.5毫克/千克酮咯酸用生理盐水稀释至10毫升。在术后1小时(T0)、6小时(T1)、12小时(T2)、24小时(T3)和36小时(T4)评估VAS、收缩压、舒张压、心率、呼吸频率、镇痛药需求及副作用。在T0和T1时,B组和C组患者的VAS较A组患者显著降低,但从T2开始差异消失。在T0和T1时,B组和C组患者的血压、心率和呼吸频率值较A组患者显著降低。然而,这些值随后趋于稳定。三组患者出现恶心和呕吐等副作用的比例各不相同。(摘要截选至250字)